Laboratory News and Research

RSS
Pertussis incidence: an interview with Leonard Friedland, M.D., V.P. and Director of Scientific Affairs and Public Health for GSK Vaccines

Pertussis incidence: an interview with Leonard Friedland, M.D., V.P. and Director of Scientific Affairs and Public Health for GSK Vaccines

Study shows plant sterols appear to prevent onset of Alzheimer's disease

Study shows plant sterols appear to prevent onset of Alzheimer's disease

Older people with diabetes more likely to develop cognitive deterioration and Alzheimer's disease

Older people with diabetes more likely to develop cognitive deterioration and Alzheimer's disease

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

Newly discovered proteins in spinal fluid can serve as markers for Alzheimer's disease

Newly discovered proteins in spinal fluid can serve as markers for Alzheimer's disease

New imaging tool could someday be used for routine breast cancer screenings

New imaging tool could someday be used for routine breast cancer screenings

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

eXtasy software suite quickly and accurately traces origins of genetic disorders

eXtasy software suite quickly and accurately traces origins of genetic disorders

EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

Scientists from University of Salzburg, Sandoz Pharmaceuticals and Thermo Fisher Scientific collaborate to advance protein-based pharmaceutical development

Scientists from University of Salzburg, Sandoz Pharmaceuticals and Thermo Fisher Scientific collaborate to advance protein-based pharmaceutical development

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

Laser technology: New system automatically analyzes water samples

Laser technology: New system automatically analyzes water samples

Illumina announces launch of TruGenome Undiagnosed Disease Test

Illumina announces launch of TruGenome Undiagnosed Disease Test

IDEXX Laboratories' revenues increase 7.2% to $338.3 million in Q3 2013

IDEXX Laboratories' revenues increase 7.2% to $338.3 million in Q3 2013

Researchers lead project to build first medical surveillance bracelet for senior citizens

Researchers lead project to build first medical surveillance bracelet for senior citizens

Study opens doors to novel treatments for aggressive brain cancer

Study opens doors to novel treatments for aggressive brain cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.